Nanomanufacturing has offered unprecedented opportunities for drug delivery and therapeutic advancements. This cutting-edge technology involves the precise manipulation and assembly of nanoscale materials to create pharmaceutical products with enhanced properties. In the realm of drug formulation, nanomanufacturing allows for the development of nanoparticles tailored to optimize drug solubility, bioavailability, and targeted delivery. This precision at the molecular level holds promise for improving the efficacy of various pharmaceutical compounds while minimizing side effects.
Furthermore, nanomanufacturing techniques, such as nanoparticle-based carriers and nanoscale fabrication processes, enable the production of innovative drug delivery systems that can traverse biological barriers, delivering therapeutic payloads with remarkable precision. The intersection of nanotechnology and pharmaceuticals not only opens new avenues for therapeutic interventions but also presents challenges related to scalability, regulatory considerations, and safety. As researchers and industry experts delve deeper into the potential of nanomanufacturing, its role in shaping the future of pharmaceuticals becomes increasingly evident, promising a paradigm shift in drug development and patient care.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico